"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,WO,A9,WO 2011/047091 A9,080-231-578-804-92X,2011-07-28,2011,US 2010/0052560 W,2010-10-13,US 25123409 P,2009-10-13,METHODS FOR TREATING TRAUMATIC BRAIN INJURY,The present disclosure provides methods of treating traumatic brain injury.,MARTEK BIOSCIENCES CORP;;UNIV WEST VIRGINIA;;BAILES JULIAN E,BAILES JULIAN E,,https://lens.org/080-231-578-804-92X,Search Report,yes,0,0,3,3,0,A61K31/20;;A61K31/20;;A61K31/232;;A61K31/232;;A61P25/00,A61K38/00,,0,0,,,,PENDING
2,US,A1,US 2011/0086914 A1,058-553-481-859-806,2011-04-14,2011,US 90404510 A,2010-10-13,US 90404510 A;;US 25123409 P,2009-10-13,Methods for Treating Traumatic Brain Injury,The present disclosure provides methods of treating traumatic brain injury.,BAILES JULIAN E,BAILES JULIAN E,WEST VIRGINIA UNIVERSITY (2010-11-18),https://lens.org/058-553-481-859-806,Patent Application,yes,18,9,3,3,0,A61K31/20;;A61K31/20;;A61K31/232;;A61K31/232;;A61P25/00,A61K31/232;;A61K31/20;;A61P25/00,514/549;;514/560,0,0,,,,DISCONTINUED
3,ES,T3,ES 2643628 T3,130-546-332-208-253,2017-11-23,2017,ES 10824055 T,2010-10-13,US 25123009 P;;US 2010/0052564 W,2009-10-13,Reducción del riesgo de efectos patológicos de lesión cerebral traumática,,DSM IP ASSETS BV;;UNIV WEST VIRGINIA,HADLEY KEVIN;;FEALEY TERENCE;;BAILES JULIAN,,https://lens.org/130-546-332-208-253,Granted Patent,no,0,0,18,18,0,A61K36/02;;A61K31/232;;A61P25/00;;A61P25/28;;A61P39/00;;A61K36/02;;A61K31/232,A61K38/00;;A61P25/00,,0,0,,,,ACTIVE
4,US,A1,US 2011/0257267 A1,096-796-896-909-726,2011-10-20,2011,US 90404910 A,2010-10-13,US 90404910 A;;US 25123009 P,2009-10-13,Reducing the Risk of Pathological Effects of Traumatic Brain Injury,The present disclosure provides methods and compositions for reducing the risk of pathological effects of traumatic brain injury.,HADLEY KEVIN;;FEALEY TERENCE;;BAILES JULIAN E,HADLEY KEVIN;;FEALEY TERENCE;;BAILES JULIAN E,DSM IP ASSETS B.V (2012-06-25);;MARTEK BIOSCIENCES CORPORATION (2010-12-22);;WEST VIRGINIA UNIVERSITY (2010-10-15),https://lens.org/096-796-896-909-726,Patent Application,yes,6,9,18,18,0,A61K36/02;;A61K31/232;;A61P25/00;;A61P25/28;;A61P39/00;;A61K36/02;;A61K31/232,A61K31/232;;A61K31/202;;A61P25/00,514/547;;514/560;;514/549,4,4,068-471-495-255-767;;034-305-630-873-035;;064-095-005-847-857;;034-305-630-873-035,10.1089/neu.2004.21.1457;;15672635;;17257165;;10.1111/j.1471-4159.2006.04371.x;;17942826;;10.1096/fj.07-9574lsf;;17257165;;10.1111/j.1471-4159.2006.04371.x,Wu et. al. (Journal or Neurotrauma (2004) 21:1457-1467).;;Farooqui et. al. (Journal of neurochemistry (2007) 101:577-599).;;Reagan-Shaw et. al. FASEB Journal (2007) 22:659-661).;;Farooqui et. al. (Journal of Neurochemistry (2007) 101:577-599).,DISCONTINUED
5,EP,A4,EP 2488190 A4,132-518-553-944-873,2013-03-27,2013,EP 10824055 A,2010-10-13,US 25123009 P;;US 2010/0052564 W,2009-10-13,REDUCING THE RISK OF PATHOLOGICAL EFFECTS OF TRAUMATIC BRAIN INJURY,,DSM IP ASSETS BV;;UNIV WEST VIRGINIA,HADLEY KEVIN;;FEALEY TERENCE;;BAILES JULIAN E,DSM IP ASSETS B.V. (2013-05-01);;WEST VIRGINIA UNIVERSITY (2013-05-01);;WEST VIRGINIA UNIVERSITY RESEARCH CORPORATION OFFI (2012-11-14),https://lens.org/132-518-553-944-873,Search Report,no,3,0,18,18,0,A61K36/02;;A61K31/232;;A61P25/00;;A61P25/28;;A61P39/00;;A61K36/02;;A61K31/232,A61K38/00;;A61P25/00,,1,0,,,See also references of WO 2011047095A1,ACTIVE
6,CA,A1,CA 2777367 A1,108-407-287-975-535,2011-04-21,2011,CA 2777367 A,2010-10-13,US 25123009 P;;US 2010/0052564 W,2009-10-13,REDUCING THE RISK OF PATHOLOGICAL EFFECTS OF TRAUMATIC BRAIN INJURY,The present disclosure provides methods and compositions for reducing the risk of pathological effects of traumatic brain injury.,MARTEK BIOSCIENCES CORP;;UNIV WEST VIRGINIA,HADLEY KEVIN;;FEALEY TERENCE;;BAILES JULIAN E,,https://lens.org/108-407-287-975-535,Patent Application,no,0,0,18,18,0,A61K36/02;;A61K31/232;;A61P25/00;;A61P25/28;;A61P39/00;;A61K36/02;;A61K31/232,,,0,0,,,,DISCONTINUED
7,WO,A1,WO 2011/047091 A1,144-990-712-787-743,2011-04-21,2011,US 2010/0052560 W,2010-10-13,US 25123409 P,2009-10-13,METHODS FOR TREATING TRAUMATIC BRAIN INJURY,The present disclosure provides methods of treating traumatic brain injury.,MARTEK BIOSCIENCES CORP;;UNIV WEST VIRGINIA;;HADLEY KEVIN;;FEALEY TIM;;BAILES JULIAN E,HADLEY KEVIN;;FEALEY TIM;;BAILES JULIAN E,,https://lens.org/144-990-712-787-743,Patent Application,yes,1,4,3,3,0,A61K31/20;;A61K31/20;;A61K31/232;;A61K31/232;;A61P25/00,A61K38/00,,2,2,068-471-495-255-767;;090-327-014-356-673,10.1089/neu.2004.21.1457;;15672635;;10.1007/s00253-003-1525-y;;14740186,"WU ET AL.: ""Dietary Omega-3 Fatty Acids Normalize BDNF Levels, Reduce Oxidative Damage, and Counteract Leaming Disability after Traumatic Brain Injury in Rats."", JOURANL OF NEUROTRAUMA, vol. 21, 2004, pages 1457 - 1464, XP008155687, DOI: doi:10.1089/neu.2004.21.1457;;SIJTSMA ET AL.: ""Biotechnological production and applications of the omega-3 polyunsaturated fatty acid docosahexaenoic acid."", APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, vol. 64, 2004, pages 146 - 153, XP008155599, DOI: doi:10.1007/s00253-003-1525-y",PENDING
8,JP,A,JP 2016053065 A,120-965-457-082-141,2016-04-14,2016,JP 2015217669 A,2015-11-05,US 25123009 P,2009-10-13,REDUCING RISK OF PATHOLOGICAL EFFECTS OF TRAUMATIC BRAIN INJURY,"PROBLEM TO BE SOLVED: To provide methods and compositions for reducing the risk of pathological effects of traumatic brain injury.SOLUTION: A method comprises: administering to a subject who is at risk of traumatic brain injury a composition comprising docosahexaenoate (DHA), where the composition is administered before the subject engages in an activity associated with a risk of traumatic brain injury. The composition has an eicosapentaenoate (EPA) content of about 3 wt.% of the total fatty acid content.SELECTED DRAWING: None",DSM IP ASSETS BV;;UNIV WEST VIRGINIA,KEVIN HADLEY;;TERENCE FEALEY;;JULIAN E BAILES,,https://lens.org/120-965-457-082-141,Patent Application,no,3,0,18,18,0,A61K36/02;;A61K31/232;;A61P25/00;;A61P25/28;;A61P39/00;;A61K36/02;;A61K31/232,A61K31/202;;A61K9/48;;A61K31/232;;A61K35/68;;A61P25/00,,3,3,068-471-495-255-767;;081-220-276-958-790;;076-224-041-545-198,10.1089/neu.2004.21.1457;;15672635;;pmc3208643;;18620024;;10.1016/j.neuroscience.2008.05.061;;16364299;;10.1016/j.expneurol.2005.09.004,"WU, A. ET AL: ""Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning"", J. NEUROTRAUMA, vol. 21, no. 10, JPN6014044088, 2004, pages 1457 - 1467, XP008151907, ISSN: 0003384706, DOI: 10.1089/neu.2004.21.1457;;WU, A. ET AL: ""Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity"", NEUROSCIENCE, vol. 155, no. 3, JPN6014044089, 2008, pages 751 - 759, XP023906498, ISSN: 0003384707, DOI: 10.1016/j.neuroscience.2008.05.061;;WU, A. ET AL: ""Dietary curcumin counteracts the outcome of traumatic brain injury on oxidative stress, synaptic pla"", EXP. NEUROL., vol. 197, no. 2, JPN6014044090, 2006, pages 309 - 317, XP024945695, ISSN: 0003384708, DOI: 10.1016/j.expneurol.2005.09.004",INACTIVE
9,JP,A,JP 2018021067 A,190-870-736-561-900,2018-02-08,2018,JP 2017174229 A,2017-09-11,US 25123009 P,2009-10-13,METHOD FOR REDUCING RISK OF PATHOLOGICAL EFFECTS OF TRAUMATIC BRAIN INJURY,"PROBLEM TO BE SOLVED: To provide a method for prophylactic treatment that reduces the risk of pathological effects associated with traumatic brain injury.SOLUTION: A method for reducing the risk of pathological effects of traumatic brain injury comprises the following step: (a) administering to a subject who is at risk of traumatic brain injury a composition comprising docosahexaenoate (DHA), where the composition is administered in a prophylactically effective amount for a sufficient time period prior to engagement in an activity associated with a risk of traumatic brain injury to reduce the risk of pathological effects of traumatic brain injury, and where the composition has an eicosapentaenoate (EPA) content of about 3 wt.% of the total fatty acid content.SELECTED DRAWING: None",DSM IP ASSETS BV;;UNIV WEST VIRGINIA,KEVIN HADLEY;;TERENCE FEALEY;;JULIAN E BAILES,,https://lens.org/190-870-736-561-900,Patent Application,no,4,1,18,18,0,A61K36/02;;A61K31/232;;A61P25/00;;A61P25/28;;A61P39/00;;A61K36/02;;A61K31/232,A61K31/202;;A61K9/42;;A61K9/48;;A61K31/232;;A61K36/02;;A61P25/00;;A61P39/00,,1,1,068-471-495-255-767,10.1089/neu.2004.21.1457;;15672635,"WU, A. ET AL: ""Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning"", J. NEUROTRAUMA, vol. 21, no. 10, JPN6014044088, 2004, pages 1457 - 1467, XP008151907, ISSN: 0003824685, DOI: 10.1089/neu.2004.21.1457",ACTIVE
10,AU,B2,AU 2010/306870 B2,064-212-011-650-700,2016-08-18,2016,AU 2010/306870 A,2010-10-13,US 25123009 P;;US 2010/0052564 W,2009-10-13,Reducing the risk of pathological effects of traumatic brain injury,The present disclosure provides methods and compositions for reducing the risk of pathological effects of traumatic brain injury.,DSM IP ASSETS BV;;UNIV WEST VIRGINIA,HADLEY KEVIN;;FEALEY TERENCE;;BAILES JULIAN E,WEST VIRGINIA UNIVERSITY RESEARCH CORPORATION OFFI (2012-09-06),https://lens.org/064-212-011-650-700,Granted Patent,no,3,0,18,18,0,A61K36/02;;A61K31/232;;A61P25/00;;A61P25/28;;A61P39/00;;A61K36/02;;A61K31/232,A61K38/00,,1,1,068-471-495-255-767,10.1089/neu.2004.21.1457;;15672635,"WU et al., Journal of Neurotrauma, 2004, Vol. 21, page 1457-1464",ACTIVE
11,US,B2,US 11413263 B2,146-244-447-174-409,2022-08-16,2022,US 201816160388 A,2018-10-15,US 201816160388 A;;US 90404910 A;;US 25123009 P,2009-10-13,Reducing the risk of pathological effects of traumatic brain injury,The present disclosure provides methods and compositions for reducing the risk of pathological effects of traumatic brain injury.,DSM IP ASSETS BV,HADLEY KEVIN;;FEALEY TERENCE;;BAILES JULIAN E,,https://lens.org/146-244-447-174-409,Granted Patent,yes,10,0,18,18,0,A61K36/02;;A61K31/232;;A61P25/00;;A61P25/28;;A61P39/00;;A61K36/02;;A61K31/232,A61K31/232;;A61K36/02,,2,2,068-471-495-255-767;;034-305-630-873-035,10.1089/neu.2004.21.1457;;15672635;;17257165;;10.1111/j.1471-4159.2006.04371.x,Wu et al. (Journal or Neurotrauma (2004) 21:1457-1467). (Year: 2004).;;Farooqui et al. (Journal of Neurochemistry (2007) 101:577-599) (Year: 2007).,ACTIVE
12,EP,B1,EP 2488190 B1,027-835-770-651-21X,2017-09-20,2017,EP 10824055 A,2010-10-13,US 25123009 P;;US 2010/0052564 W,2009-10-13,REDUCING THE RISK OF PATHOLOGICAL EFFECTS OF TRAUMATIC BRAIN INJURY,,DSM IP ASSETS BV;;UNIV WEST VIRGINIA,HADLEY KEVIN;;FEALEY TERENCE;;BAILES JULIAN E,DSM IP ASSETS B.V. (2013-05-01);;WEST VIRGINIA UNIVERSITY (2013-05-01);;WEST VIRGINIA UNIVERSITY RESEARCH CORPORATION OFFI (2012-11-14),https://lens.org/027-835-770-651-21X,Granted Patent,yes,4,0,18,18,0,A61K36/02;;A61K31/232;;A61P25/00;;A61P25/28;;A61P39/00;;A61K36/02;;A61K31/232,A61K38/00;;A61P25/00,,2,0,,,"WU ET AL.: 'Dietary Omega-3 Fatty Acids Normalize BDNF Levels, Reduce Oxidative Damage, and Counteract Leaming Disability after Traumatic Brain Injury in Rats.' JOURANL OF NEUROTRAUMA vol. 21, 2004, pages 1457 - 1464, XP008155687;;SIJTSMA ET AL.: 'Biotechnological production and applications of the omega-3 polyunsaturated fatty acid docosahexaenoic acid.' APPLIED MICROBIOLOGY AND BIOTECHNOLOGY vol. 64, 2004, pages 146 - 153, XP008155599",ACTIVE
13,AU,A1,AU 2010/306870 A1,023-574-998-678-680,2012-05-03,2012,AU 2010/306870 A,2010-10-13,US 25123009 P;;US 2010/0052564 W,2009-10-13,Reducing the risk of pathological effects of traumatic brain injury,The present disclosure provides methods and compositions for reducing the risk of pathological effects of traumatic brain injury.,WEST VIRGINA UNIVERSITY RES CORP OFFICE OF TECHNOLOGY TRANSFER;;MARTEK BIOSCIENCES CORP,HADLEY KEVIN;;FEALEY TERENCE;;BAILES JULIAN E,WEST VIRGINIA UNIVERSITY RESEARCH CORPORATION OFFI (2012-09-06),https://lens.org/023-574-998-678-680,Patent Application,no,0,0,18,18,0,A61K36/02;;A61K31/232;;A61P25/00;;A61P25/28;;A61P39/00;;A61K36/02;;A61K31/232,A61K38/00,,0,0,,,,ACTIVE
14,PL,T3,PL 2488190 T3,170-504-020-497-16X,2018-02-28,2018,PL 10824055 T,2010-10-13,US 25123009 P;;EP 10824055 A;;US 2010/0052564 W,2009-10-13,REDUCING THE RISK OF PATHOLOGICAL EFFECTS OF TRAUMATIC BRAIN INJURY,,DSM IP ASSETS BV;;UNIV WEST VIRGINIA,HADLEY KEVIN;;FEALEY TERENCE;;BAILES JULIAN E,,https://lens.org/170-504-020-497-16X,Patent Application,no,0,0,18,18,0,A61K36/02;;A61K31/232;;A61P25/00;;A61P25/28;;A61P39/00;;A61K36/02;;A61K31/232,A61K38/00;;A61P25/00,,0,0,,,,PENDING
15,WO,A1,WO 2011/047095 A1,166-760-269-824-697,2011-04-21,2011,US 2010/0052564 W,2010-10-13,US 25123009 P,2009-10-13,REDUCING THE RISK OF PATHOLOGICAL EFFECTS OF TRAUMATIC BRAIN INJURY,The present disclosure provides methods and compositions for reducing the risk of pathological effects of traumatic brain injury.,MARTEK BIOSCIENCES CORP;;UNIV WEST VIRGINIA;;HADLEY KEVIN;;FEALEY TIM;;BAILES JULIAN E,HADLEY KEVIN;;FEALEY TIM;;BAILES JULIAN E,,https://lens.org/166-760-269-824-697,Patent Application,yes,7,7,18,18,0,A61K36/02;;A61K31/232;;A61P25/00;;A61P25/28;;A61P39/00;;A61K36/02;;A61K31/232,A61K38/00,,31,20,068-471-495-255-767;;090-327-014-356-673;;005-265-730-502-180;;001-299-078-933-333;;081-268-677-394-589;;030-699-667-382-220;;090-327-014-356-673;;003-359-482-719-94X;;007-135-074-407-755;;060-388-613-366-743;;087-213-747-858-853;;098-576-409-457-258;;050-615-633-841-200;;125-358-674-530-50X;;102-013-686-296-134;;110-016-876-104-74X;;052-854-100-079-39X;;063-427-079-996-240;;015-263-288-490-749;;052-854-100-079-39X,10.1089/neu.2004.21.1457;;15672635;;10.1007/s00253-003-1525-y;;14740186;;10.1089/neu.2000.17.927;;11063058;;10.1126/science.284.5412.339;;010195903;;10195903;;pmc6772193;;10.1523/jneurosci.20-08-02825.2000;;10751434;;11063050;;10.1089/neu.2000.17.811;;10.1007/s00253-003-1525-y;;14740186;;17251724;;10.1097/01.ccm.0000254442.66789.52;;pmc2581618;;18657524;;10.1016/j.brainres.2008.07.006;;10.1227/01.neu.0000163407.92769.ed;;15987548;;17143242;;10.1227/01.neu.0000245601.69451.27;;10.1097/00006123-200605000-00037;;10786712;;10.1023/a:1007583806138;;10.1016/j.chroma.2006.06.089;;16893549;;10.1016/0031-9422(88)80425-4;;10.1097/mjt.0b013e31817fe2be;;19145206;;10.3171/jns.1994.80.2.0301;;8283270;;10.1007/s004010050996;;10208272;;12880338;;10.1117/1.1584443;;17901087;;10.1093/brain/awm223;;10.1007/s004010050996;;10208272,"WU ET AL.: ""Dietary Omega-3 Fatty Acids Normalize BDNF Levels, Reduce Oxidative Damage, and Counteract Leaming Disability after Traumatic Brain Injury in Rats."", JOURANL OF NEUROTRAUMA, vol. 21, 2004, pages 1457 - 1464, XP008155687;;SIJTSMA ET AL.: ""Biotechnological production and applications of the omega-3 polyunsaturated fatty acid docosahexaenoic acid."", APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, vol. 64, 2004, pages 146 - 153, XP008155599;;RAGHUPATHI R ET AL., J NEUROTRAUMA., vol. 17, 2000, pages 927 - 938;;WANG ET AL., SCIENCE, vol. 284, 1999, pages 339 - 343;;BUKI ET AL., J.NEUROSCI., vol. 20, 2000, pages 2825 - 2834;;ELDADAH ET AL., J.NEUROTRAUMA., vol. 17, no. 10, 2000, pages 811 - 829;;WU ET AL., JOURMAL OF NEUROTRAUMA, vol. 21, 2005, pages 1457 - 1464;;SIJTSMA ET AL., APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, vol. 64, 2004, pages 146 - 153;;HOVDA, CRIT CARE MED., vol. 35, 2007, pages 663 - 664;;AOYAMA ET AL., BRAIN RES., vol. 1230, 9 July 2008 (2008-07-09), pages 310 - 319;;OMALU ET AL., NEUROSURGERY, vol. 57, 2005, pages 128 - 134;;OMALU ET AL., NEUROSURGERY, vol. 59, 2006, pages 1086 - 1092;;HOMAYOUN ET AL., NEUROCHEMICAL RESEARCH, vol. 25, 2000, pages 269 - 276;;FOURNIER ET AL., J CHROMATOGR A., vol. 1129, 2006, pages 21 - 28;;HENDERSON ET AL., PHYTOCHEMISTRY, vol. 27, 1988, pages 1679 - 1683;;HIGUCHI, T.; V. STELLA: ""Pro-drugs as Novel Delivery Systems"", vol. 14, A.C.S. SYMPOSIUM SERIES;;""Bioreversible Carriers in Drug Design"", 1987, AMERICAN PHARMACEUTICAL ASSOCIATION, PERGAMON PRESS;;""Protective Groups in Organic Chemistry"", 1973, PLENUM PRESS;;RYAN ET AL., AMER. J. THERAPEUTICS, vol. 16, 2009, pages 183 - 192;;BANKER; RHODES: ""Modem Pharmaceutics"", 2002, INFORMA HEALTHCARE;;""Goodman & Gilman's The Pharmaceutical Basis o/Therapeutics"", 2001, MCGRAW-HILL;;BELAYEV ET AL., STROKE, vol. 36, 29 November 2004 (2004-11-29), pages 118 - 123;;""Goodman & Gilman's The Pharmaceutical Basis of Therapeutics"", 2001, MCGRAW-HILL;;""Remingtons's Pharmaceutical Sciences"", 2001;;FODA; MARMAROU, J NEUROSURG, vol. 80, 1994, pages 301 - 313;;""Guide for the Care and Use of Laboratory animals"", NIH PUBLICATION 85-23-2985;;STONE ET AL., ACTA NEUROPATHOL, vol. 97, 1999, pages 335 - 345;;MILLS ET AL., J BIOMED OPT, vol. 8, 2003, pages 347 - 356;;HUANG ET AL., BRAIN, vol. 130, 2007, pages 3004 - 3019;;STONE ET AL., ACTA NEUROPATHOL, vol. 97, pages 335 - 345;;See also references of EP 2488190A4",PENDING
16,EP,A1,EP 2488190 A1,027-038-979-043-870,2012-08-22,2012,EP 10824055 A,2010-10-13,US 25123009 P;;US 2010/0052564 W,2009-10-13,REDUCING THE RISK OF PATHOLOGICAL EFFECTS OF TRAUMATIC BRAIN INJURY,,MARTEK BIOSCIENCES CORP;;UNIV WEST VIRGINIA,HADLEY KEVIN;;FEALEY TERENCE;;BAILES JULIAN E,DSM IP ASSETS B.V. (2013-05-01);;WEST VIRGINIA UNIVERSITY (2013-05-01);;WEST VIRGINIA UNIVERSITY RESEARCH CORPORATION OFFI (2012-11-14),https://lens.org/027-038-979-043-870,Patent Application,yes,0,2,18,18,0,A61K36/02;;A61K31/232;;A61P25/00;;A61P25/28;;A61P39/00;;A61K36/02;;A61K31/232,A61K38/00;;A61P25/00,,0,0,,,,ACTIVE
17,AU,A8,AU 2010/306870 A8,111-367-815-655-047,2012-06-28,2012,AU 2010/306870 A,2010-10-13,US 25123009 P;;US 2010/0052564 W,2009-10-13,Reducing the risk of pathological effects of traumatic brain injury,The present disclosure provides methods and compositions for reducing the risk of pathological effects of traumatic brain injury.,UNIV WEST VIRGINIA;;MARTEK BIOSCIENCES CORP,HADLEY KEVIN;;FEALEY TERENCE;;BAILES JULIAN E,WEST VIRGINIA UNIVERSITY RESEARCH CORPORATION OFFI (2012-09-06),https://lens.org/111-367-815-655-047,Patent Application,no,0,0,18,18,0,A61K36/02;;A61K31/232;;A61P25/00;;A61P25/28;;A61P39/00;;A61K36/02;;A61K31/232,A61K38/00,,0,0,,,,ACTIVE
18,US,A1,US 2019/0046495 A1,136-818-564-649-423,2019-02-14,2019,US 201816160388 A,2018-10-15,US 201816160388 A;;US 90404910 A;;US 25123009 P,2009-10-13,Reducing the Risk of Pathological Effects of Traumatic Brain Injury,The present disclosure provides methods and compositions for reducing the risk of pathological effects of traumatic brain injury.,DSM IP ASSETS BV,HADLEY KEVIN;;FEALEY TERENCE;;BAILES JULIAN E,,https://lens.org/136-818-564-649-423,Patent Application,yes,0,1,18,18,0,A61K36/02;;A61K31/232;;A61P25/00;;A61P25/28;;A61P39/00;;A61K36/02;;A61K31/232,A61K31/232;;A61K36/02,,0,0,,,,ACTIVE
